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The fruits of Nandina domestica THUNBERG (ND), called in "nantenjitsu" in Japan, have been used for the treatment of respiratory diseases such as asthma, whooping cough and pharynx tumor for many years in Japan. 1) However, little is known about mechanisms underlying its pharmacological action. Since the trachea is a lower respiratory tract that controls respiratory air flow, it is possible that ND improves breathing difficulty by relaxing tracheal smooth muscles. To examine this possibility, in the present study, we investigated effects of the crude extract from ND (NDE) on contractile responses of isolated trachea in vitro.
Although chemical studies on the constituents of NDE have revealed that it contains numerous alkaloids, it remains unclear which constituent is responsible for beneficial effects of NDE in treating respiratory disorders. Nantenine (9,10-methylenedioxy-1,2 dimethoxyaporphine or O-methyldomesticine) is a major alkaloid isolated from NDE, 1) and has been reported to show several pharmacological activities. For example, nantenine (3 mM) competitively inhibited serotonin-induced contractile responses in isolated rabbit aorta and isolated rat stomach, 2) suggesting that it is a serotonergic receptor antagonist. Nantenine (0.3-3 mM) competitively inhibited phenylephrine-induced contraction in isolated rat aorta, 3) suggesting that it is also an a 1 -adrenoceptor antagonist. Nantenine at higher concentrations (2.35, 4.7ϫ10 Ϫ4 M) inhibited KCl-induced increase in intracellular Ca 2ϩ concentration and contraction in isolated rat vas deferens, 4) suggesting that it works like Ca 2ϩ antagonists. Intravenous administration of nantenine (3-6 mg/kg) produced dose-dependent decreases in mean arterial blood pressure and heart rate in anesthetized rats. 5) Intraperitoneal administration of nantenine (20-50 mg/kg) inhibited pentylenetetrazol-and electroshock-induced seizures in mice.
6) The chemical structure of nantenine is similar to that of 3,4-methylenedioxymethamphetamine (MDMA), which is a "club drug" often sold under the name of ecstasy, and nantenine blocked MDMA-induced hyperthermia in mice. 7) However, to the best of our knowledge, there has been no report describing pharmacological effects of nantenine on the respiratory system. Therefore, we compared the effects of NDE and nantenine in the present study. Contractile responses of tracheal smooth muscles are regulated by various neurotransmitters and autacoids including acetylcholine, histamine, serotonin, etc. [8] [9] [10] [11] As mentioned above, nantenine has been reported to inhibit serotonin-induced contractile responses in isolated rabbit aorta and isolated rat stomach.
2) It is possible that NDE and nantenine affect serotonin-induced contraction of tracheal smooth muscles. Therefore, in the present study, we used acetylcholine, histamine and serotonin as stimulants to induce tracheal contraction. Furthermore, we chose the guinea pig as an experimental animal, because it is well known that the guinea pig trachea responds more sensitively to histamine and serotonin than the rat trachea.
MATERIALS AND METHODS
Drugs and Chemicals NDE was manufactured through a conventional process by Tokiwa Pharmaceutical Co., Ltd., Noevir Group (Osaka, Japan). Briefly, the dried fruits of ND were extracted with 10 parts of hot water (90-100°C) for 1 h, and the solution was spray-dried to give NDE. The yield of NDE was 25.0%. To verify the quality of NDE, the content of nantenine in NDE was checked with gas chromatography. NDE used in the present study contained 0.67% nantenine. The NDE was suspended in distilled water and sonicated at room temperature for 10 min before use. Nantenine was obtained from Matsuura Yakugyo Co., Ltd. (Nagoya, Japan). Nantenine was first dissolved at the concentration of 2 mM in 0.01 N HCl, and then pH was adjusted to 7.0 by adding appropriate volume of 0.1 N NaOH. The nantenine solution was diluted to desired concentrations by distilled water immediately before use. Acetylcholine chloride, histamine, indomethacin, ketanserin tartrate and serotonin hydrochloride were purchased from Sigma Chemical (St. September 5, 2007 U.S.A.). Atropine sulfate monohydrate, diphenhydramine hydrochloride and papaverine hydrochloride were from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All other chemicals were of reagent grade from Wako.
Animal and Tracheal Tissue Preparation All experiments were performed in accordance with the "Guiding Principles for the Care and Use of Laboratory Animals" approved by the Japanese Pharmacological Society. The trachea was isolated from 6-9-week-old male Hartley guinea pigs (Tokyo Laboratory Animals Science, Tokyo, Japan), weighing 350-550 g, and immersed in Krebs-Henseliet (K-H) solution (118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 25 mM NaHCO 3 , 10 mM glucose) gassed with 95% O 2 /5% CO 2 (pH 7.4). The trachea was carefully cleaned of unnecessary adipose and connective tissues, and cut into transverse strips of two adjacent cartilage rings (2-3 mm wide).
Measurement of Contractile Responses Each tracheal ring preparation was mounted in a 5-ml organ bath (UC-5TD; UFER Medical Instrument, Kyoto, Japan) at a resting tension of 0.5 g weight (approximately 5 mN). The bath contained K-H solution maintained at 32°C and gassed with 95% O 2 /5% CO 2 . The isometric tension was measured with a force displacement transducer. Before testing effects of drugs, the tracheal ring preparations were allowed to equilibrate for 60 min, during which time the bathing solution was removed and replaced with fresh K-H solution every 20 min and changes in resting tension were adjusted back to 0.5 g weight. At the end of the equilibration, the ring preparation was contracted with 10 mM acetylcholine to ensure stabilization of the smooth muscles. After the contraction reached a steady state, the tissue was rinsed several times with fresh K-H solution until tension returned to the resting level. Concentration-response curves were then constructed by cumulative addition of acetylcholine, histamine or serotonin. In case histamine or serotonin was used as a contractile agent, atropine (1 mM) and indomethacin (10 mM) were added to the bathing solution in order to abolish the basal, tonic contraction possibly produced by endogenous acetylcholine or arachidonate metabolites. 12, 13) Since guinea pig tracheal smooth muscles contracted very slowly and it usually took 1-2 h to obtain one cumulative concentration-response curve, only one concentration of NDE, nantenine or other antagonists was tested on each tissue. The first concentration-response curve for an agonist was constructed in the absence of NDE, nantenine or other antagonists. The same tissue was pre-incubated with one concentration of NDE, nantenine or other antagonists for 10 min, and the second concentration-response curve for the same agonist was constructed in the presence of NDE, nantenine or other antagonists.
Data Analysis The concentration-response curves were analyzed for each experiment. The magnitude of contraction induced by each agonist in each condition was expressed as the percentage of the maximal contraction induced by the agonist in the first concentration-response curve (control). Median effective concentrations (EC 50 values) for agonists were calculated as described previously. 14) Data are presented as the meansϮS.E.M. of n independent observations. Significance of the differences was determined with Student's t-test.
RESULTS
As shown in Fig. 1A , cumulative addition of acetylcholine at concentrations of 10 Ϫ9 to 10 Ϫ2 M produced a concentration-dependent contraction in guinea pig tracheal ring preparations used in the present study. In normal condition, addition of 1 mg/ml NDE alone caused a decrease in basal tone of the preparation. Cumulative addition of acetylcholine in the presence of 1 mg/ml NDE produced a concentration-dependent contraction. The effects of acetylcholine in the absence and presence of 1 mg/ml NDE were summarized as in Fig. 1B . The basal tone was decreased by the presence of NDE, but maximal contraction induced by acetylcholine was not different in the absence and presence of NDE. The concentration-response curve for acetylcholine was slightly shifted to the right by the presence of 1 mg/ml NDE. The EC 50 values of acetylcholine were increased by the presence of 1 mg/ml NDE, from 2.48Ϯ0.56 mM (nϭ5) to 8.29Ϯ 1.70 mM (nϭ5; pϽ0.01 by Student's t-test). As a positive control, the effect of the muscarinic receptor antagonist atropine was also checked. The EC 50 values of acetylcholine were increased by the presence of 10 Ϫ7 M atropine, from 1.94Ϯ0.70 mM (nϭ5) to 352.37Ϯ46.62 mM (nϭ5; pϽ0.01 by Student's t-test).
The guinea pig tracheal ring preparations used in the present study appeared to tonically contract during the resting state in normal experimental conditions. In fact, addition of papaverine (3 mM) caused a relaxation of the preparation (Fig.  2A) . After the preparation was relaxed by addition of 1 mg/ml NDE, papaverine caused no further relaxation, indicating that NDE at 1 mg/ml produces maximal relaxation of the trachea (Fig. 2B) . The presence of the basal tone should make it difficult to quantitatively analyze the effect of NDE on tracheal responses to drugs. Since the basal tone is likely to be produced by endogenous acetylcholine or arachidonate metabolites, 12, 13) the following experiments were done under the presence of atropine, a muscarinic acetylcholine receptor antagonist, and indomethacin, a cyclooxygenase inhibitor. In a K-H solution supplemented with atropine (1 mM) and indomethacin (10 mM), the basal tone was abolished, and addition of NDE or papaverine caused no change in the baseline (Fig. 2C) .
In the presence of atropine and indomethacin, concentration-response curves for histamine and serotonin were constructed. As shown in Fig. 3 , cumulative addition of histamine produced a concentration-dependent contraction in guinea pig tracheal ring preparations. The tracheal response to histamine was not affected by the presence of 0.01 mg/ml NDE (Fig. 3A) , but significantly inhibited by the presence of 0.1 mg/ml NDE (Fig. 3B) . The EC 50 values of histamine were increased by the presence of 0.1 mg/ml NDE, from 1.12Ϯ0.10 mM (nϭ5) to 2.24Ϯ0.29 mM (nϭ5; pϽ0.01). The histamine-induced maximal contraction was decreased to 90.0Ϯ3.1% (nϭ5) by 0.1 mg/ml NDE. The tracheal response to histamine was further inhibited by the presence of 1 mg/ml NDE (Fig. 3C) . The EC 50 values of histamine were increased by the presence of 1 mg/ml NDE, from 0.76Ϯ0.10 mM (nϭ5) to 5.94Ϯ0.67 mM (nϭ5; pϽ0.01). The histamine-induced maximal contraction was decreased to 55.4Ϯ2.5% (nϭ5) by 1 mg/ml NDE. As a positive control, the effect of the histamine H 1 receptor antagonist diphenhydramine was also checked. The EC 50 values of histamine were increased by the presence of 10 Ϫ6 M diphenhydramine, from 0.74Ϯ0.13 mM (nϭ5) to 15.9Ϯ2.4 mM (nϭ5; pϽ0.01).
As shown in Fig. 4 , cumulative addition of serotonin produced a concentration-dependent contraction in guinea pig tracheal ring preparations. The concentration-response curve for serotonin was slightly shifted to the right by the presence of 0.01 mg/ml NDE (Fig. 4A) . The EC 50 values of serotonin were increased by the presence of 0.01 mg/ml NDE, from 0.20Ϯ0.03 mM (nϭ5) to 0.33Ϯ0.04 mM (nϭ5; pϽ0.05). The concentration-response curve for serotonin was further shifted to the right by the presence of 0.1 mg/ml NDE (Fig.  4B ) and 1 mg/ml NDE (Fig. 4C) . Since it was hard to obtain serotonin-induced maximal contraction in the presence of 0.1 and 1 mg/ml NDE (Figs. 4B, C) , we were not able to quantitatively analyze the effects of 0.1 and 1 mg/ml NDE on the potency and efficacy of serotonin. As a positive control, the effect of the serotonin 5-HT 2A receptor antagonist ketanserin was also checked. The EC 50 values of serotonin were increased by the presence of 10 Ϫ8 M ketanserin, from 0.08Ϯ0.01 mM (nϭ5) to 0.74Ϯ0.15 mM (nϭ5; pϽ0.01). Since chemical analysis with gas chromatography revealed that NDE contained 0.67% nantenine (molecular weight; 339.385), nantenine was estimated to be present at approximately 20 mM in 1 mg/ml NDE. Therefore, we investigated the effects of nantenine at 0.2, 2 and 20 mM on histamine-and serotonin-induced contraction. As shown in Fig. 5 , histamine-induced contraction was not at all affected by the presence of 0.2-20 mM nantenine. As shown in Fig. 6A , serotonin-induced contraction seemed to be augmented by 0.2 mM nantenine, but the effect of nantenine was not statistically significant. The concentration-response curve for serotonin was slightly shifted to the right by the presence of 2 mM nantenine (Fig. 6B) . The EC 50 values of serotonin were increased by the presence of 2 mM nantenine, from 0.19Ϯ0.05 mM (nϭ5) to 0.50Ϯ0.05 mM (nϭ5; pϽ0.01). The concentrationresponse curve for serotonin was further shifted to the right by the presence of 20 mM nantenine (Fig. 6C) . The EC 50 values of serotonin were increased by the presence of 20 mM nantenine, from 0.28Ϯ0.05 mM (nϭ5) to 4.24Ϯ0.52 mM (nϭ5; pϽ0.01). The inhibitory effect of nantenine on serotonin-induced contraction (Fig. 6 ) was weaker than that of NDE (Fig. 4) . DISCUSSION NDE at 1 mg/ml caused a relaxation in tonically contracted tracheal preparations (Fig. 1) . This is the first report demonstrating that NDE relaxes tracheal smooth muscles. The basal, tonic contraction of isolated guinea pig tracheal preparations was abolished by atropine and indomethacin (Fig. 2) , indicating that it is produced by endogenous acetylcholine and arachidonate metabolites, as previously reported. 12, 13) The concentration-response curve for acetylcholine was shifted to the right by 3.3-fold in the presence of 1 mg/ml NDE (Fig. 1B) , suggesting that NDE has a weak anti-cholinergic action. However, the inhibitory effect of NDE on acetylcholine-induced contraction was very slight, and cannot account for NDE-induced decrease in the basal tone. It is possible that NDE relaxes tracheal smooth muscles through non-specific mechanisms like papaverine or Ca antagonists. This possibility is under investigation in our laboratory.
The main finding in the present study was that NDE inhibited histamine-and serotonin-induced tracheal contraction. The concentration-response curve for histamine was shifted to the right by 2.0-and 7.8-fold in the presence of 0.1 and 1 mg/ml NDE, respectively (Figs. 3B, C) . The maximal contraction induced by histamine was decreased to 90 and 55% in the presence of 0.1 and 1 mg/ml NDE, respectively. These results suggest that NDE at 0.1-1 mg/ml inhibits histamineinduced tracheal contraction through both competitive antagonism at histamine receptors and non-competitive smooth muscle relaxant mechanism. It has previously been reported that histamine-induced contraction of isolated guinea pig trachea is mediated by histamine H 1 receptors, 13, 15) and we have confirmed in the present study that histamine-induced tracheal contraction is competitively blocked by the H 1 receptor antagonist diphenhydramine. Therefore, NDE at 0.1 mg/ml NDE at 1 mg/ml did not affect acetylcholine-induced maximal contraction (Fig. 1B) , but significantly decreased histamine-induced maximal contraction (Fig. 3C ). This may be attributed to differences in the efficacy of acetylcholine and histamine in inducing tracheal contraction. It has been reported that acetylcholine-induced tracheal contraction is less sensitive to Ca 2ϩ antagonists than histamine-induced contraction. 16, 17) Therefore, it is conceivable that NDE has smooth muscle relaxant properties like Ca 2ϩ antagonists. NDE also inhibited serotonin-induced tracheal contraction. The concentration-response curve for serotonin was shifted to the right by 1.7-fold in the presence of 0.01 mg/ml NDE (Fig. 4A ). Although we were not able to exactly calculate the EC 50 values of serotonin in the presence of 0.1 and 1 mg/ml NDE in Figs. 4B and C, the concentration-response curve for serotonin appeared to be shifted to the right by approximately 100-and 1000-fold in the presence of 0.1 and 1 mg/ml NDE, respectively. These results suggest that NDE antagonizes approximately 10 times more potently against serotonin than against histamine. It has previously been reported that serotonin-induced contraction of isolated guinea pig trachea is mediated by serotonin 5-HT 2A receptors, 12, 15, [18] [19] [20] and we have confirmed in the present study that serotonin-induced tracheal contraction is competitively blocked by the 5-HT 2A receptor antagonist ketanserin. Therefore, NDE at 0.01 mg/ml or more is likely to bind to 5-HT 2A receptors and antagonize 5-HT 2A receptor-mediated responses in tracheal smooth muscles.
Chemical analysis has revealed that NDE at 0.01-1 mg/ml contains nantenine at 0.2-20 mM. NDE at 0.1-1 mg/ml inhibited histamine-induced tracheal contraction (Fig. 3) , while nantenine at 0.2-20 mM had no effect (Fig.  5) . These results suggest that nantenine is not responsible for the inhibitory effect of NDE on histamine-induced tracheal contraction.
Nantenine at 2-20 mM inhibited serotonin-induced tracheal contraction (Fig. 6) . The concentration-response curve for serotonin was shifted to the right in the presence of nantenine. It has previously been reported that nantenine at 3 mM competitively inhibited serotonin-induced contractile responses in isolated rabbit aorta and isolated rat stomach. 2) These results suggest that nantenine competitively antagonizes 5-HT 2A receptor-mediated responses in the trachea as well as in the aorta or stomach. Therefore, nantenine may be partly responsible for the anti-serotonergic effect of NDE. However, the inhibitory effect of nantenine on serotonin-induced tracheal contraction ( Fig. 6 ) was much less potent than that of NDE (Fig. 4) . NDE at 1 mg/ml shifted the concentration-response curve for serotonin by approximately 1000-fold (Fig. 4C) , while nantenine at 20 mM shifted by 15.1-fold (Fig. 6C) . It is possible that NDE contains more potent serotonin receptor antagonist than nantenine.
In conclusion, we have found for the first time that NDE acts as a non-competitive smooth muscle relaxant and competitive antagonists at H 1 receptors and 5-HT 2A receptors in tracheal smooth muscles. The antagonistic potency of NDE is approximately 10 times higher against serotonin than against histamine. Nantenine is not responsible for the antihistaminergic effect of NDE, but may partly contribute to the anti-serotonergic effect of NDE. Since nantenine cannot account solely for the inhibitory effects of NDE on tracheal smooth muscle contraction, we are exploring other bioactive constituent(s) in NDE than nantenine.
